Report Detail

Biotechnology Global Immunosuppressants Market, 2021-2027

  • RnM4344189
  • |
  • 22 September, 2021
  • |
  • Global
  • |
  • 87 Pages
  • |
  • Gen Consulting Company
  • |
  • Biotechnology

Part 1. Introduction

  • 1.1 Market Definition
  • 1.2 Key Benefit
  • 1.3 Market Segment

Part 2. Methodology

  • 2.1 Primary
  • 2.2 Secondary

Part 3. Executive Summary

    Part 4. Market Overview

    • 4.1 Introduction
    • 4.2 Market Size and Forecast
    • 4.3 Market Dynamics
      • 4.3.1 Drivers
      • 4.3.2 Restraints
    • 4.4 Impact of COVID-19 Pandemic

    Part 5. Global Market for Immunosuppressants by Indication

    • 5.1 Autoimmune Disorders
      • 5.1.1 Market Size and Forecast
    • 5.2 Organ Transplantation
      • 5.2.1 Market Size and Forecast
    • 5.3 Others
      • 5.3.1 Market Size and Forecast

    Part 6. Global Market for Immunosuppressants by Drug Class

    • 6.1 Calcineurin Inhibitors
      • 6.1.1 Market Size and Forecast
    • 6.2 Corticosteroids
      • 6.2.1 Market Size and Forecast
    • 6.3 Monoclonal Antibodies (Mabs)
      • 6.3.1 Market Size and Forecast
    • 6.4 Mtor Inhibitors
      • 6.4.1 Market Size and Forecast

    Part 7. Global Market for Immunosuppressants by Distribution Channel

    • 7.1 Hospital Pharmacies
      • 7.1.1 Market Size and Forecast
    • 7.2 Online Pharmacy
      • 7.2.1 Market Size and Forecast
    • 7.3 Retail Pharmacies
      • 7.3.1 Market Size and Forecast
    • 7.4 Others
      • 7.4.1 Market Size and Forecast

    Part 8. Global Market for Immunosuppressants by Region

    • 8.1 Asia-Pacific
      • 8.1.1 Market Size and Forecast
    • 8.2 Europe
      • 8.2.1 Market Size and Forecast
    • 8.3 North America
      • 8.3.1 Market Size and Forecast
    • 8.4 Middle East And Africa (Mea)
      • 8.4.1 Market Size and Forecast
    • 8.5 South America
      • 8.5.1 Market Size and Forecast

    Part 9. Key Competitor Profiles

    • 9.1 AbbVie Inc.
    • 9.2 Astellas Pharma Inc.
    • 9.3 Bristol Myers Squibb (BMS)
    • 9.4 GlaxoSmithKline plc (GSK)
    • 9.5 Intas Pharmaceuticals Limited
    • 9.6 Johnson & Johnson
    • 9.7 Mylan N.V.
    • 9.8 Novartis International AG
    • 9.9 Pfizer Inc.
    • 9.10 Sanofi S.A.

    *LIST IS NOT EXHAUSTIVE

      Part 10. Patent Analysis

      • 10.1 Patent Statistics
      • 10.2 Regional Analysis
      • 10.3 Trends Analysis

      DISCLAIMER

        ABOUT GEN CONSULTING COMPANY

        The global immunosuppressants market is projected to grow at a compound annual growth rate (CAGR) of 13.5% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

        The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global immunosuppressants market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

        The immunosuppressants market is segmented on the basis of indication, drug class, distribution channel, and region. The immunosuppressants market is segmented as below:

        By Indication:
        - autoimmune disorders
        - organ transplantation
        - others

        By Drug Class:
        - calcineurin inhibitors
        - corticosteroids
        - monoclonal antibodies (mAbs)
        - mTOR inhibitors

        By Distribution Channel:
        - hospital pharmacies
        - online pharmacy
        - retail pharmacies
        - others

        By Region:
        - region
        - Asia-Pacific
        - Europe
        - North America
        - Middle East and Africa (MEA)
        - South America

        The immunosuppressants industry is characterized by a high level of market share concentration. The market research report covers the analysis of key stake holders of the immunosuppressants market. Some of the leading players profiled in the report include AbbVie Inc., Astellas Pharma Inc., Bristol Myers Squibb (BMS), GlaxoSmithKline plc (GSK), Intas Pharmaceuticals Limited, Johnson & Johnson, Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi S.A., among others.
        *list is not exhaustive, request free sample to get a complete list of companies

        Historical & Forecast Period
        This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

        Scope of the Report
        - To analyze and forecast the market size of the global immunosuppressants market.
        - To classify and forecast the global immunosuppressants market based on indication, drug class, distribution channel, and region.
        - To identify drivers and challenges for the global immunosuppressants market.
        - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global immunosuppressants market.
        - To conduct pricing analysis for the global immunosuppressants market.
        - To identify and analyze the profile of leading players operating in the global immunosuppressants market.

        Why Choose This Report
        - Gain a reliable outlook of the global immunosuppressants market forecasts from 2021 to 2027 across scenarios.
        - Identify growth segments for investment.
        - Stay ahead of competitors through company profiles and market data.
        - The market estimate for ease of analysis across scenarios in Excel format.
        - Strategy consulting and research support for three months.
        - Print authentication provided for the single-user license.


        Summary:
        Get latest Market Research Reports on Immunosuppressants. Industry analysis & Market Report on Immunosuppressants is a syndicated market report, published as Global Immunosuppressants Market, 2021-2027. It is complete Research Study and Industry Analysis of Immunosuppressants market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,400.00
        $3,600.00
        $4,800.00
        1,744.80
        2,617.20
        3,489.60
        2,066.40
        3,099.60
        4,132.80
        274,248.00
        411,372.00
        548,496.00
        180,648.00
        270,972.00
        361,296.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report